诺唯赞 (688105)
Nanjing Vazyme Biotech Co., Ltd.
K-Line Chart
No K-line data available
Company NameNanjing Vazyme Biotech Co., Ltd.
Listing Date2021-11-15
Issue Price55RMB
Registered Capital39773.454410k RMB
Legal RepresentativeCao Lin
Registered AddressFloors 1-6, East Section, Building C1-2, Hongfeng Science Park, Ke Chuang Road, Nanjing Economic and Technological Development Zone, Jiangsu Province
IndustryBiological Products
Main BusinessTechnology R&D and product development centered on functional proteins such as enzymes, antigens, antibodies, and polymer organic materials.
Company ProfileNanjing Vazyme Biotech Co., Ltd. holds a total of 32 patents, including 19 invention patents, and 67 China Medical Device Registration Certificates. The company has successively established the Jiangsu Provincial Engineering Research Center, Jiangsu Provincial Enterprise Technology Center, and Jiangsu Provincial Postdoctoral Innovation Practice Base. It has undertaken several major provincial and municipal special projects and funding programs, including the Jiangsu Provincial Department of Science and Technology's Special Project for the Transformation of Scientific and Technological Achievements, the Jiangsu Provincial Department of Industry and Information Technology's Key Area Common Technology Tackling Project, and the Jiangsu Provincial Development and Reform Commission's Special Project for Nucleic Acid Detection Reagent and Vaccine/Drug R&D and Production Enterprises. The company has been honored with numerous titles such as Jiangsu Provincial Technology Little Giant Enterprise, Jiangsu Provincial Service-Oriented Manufacturing Demonstration Cultivation Enterprise, and Nanjing Cultivated Unicorn.
Stock Details
1. Key Indicators
- Total Shares(W): 734059.07
- Circulating A-Shares(W): 734059.07
- Earnings Per Share(RMB): 1.23
- Net Assets Per Share(RMB): 5.67
- Operating Revenue(W RMB): 1345261.60
- Total Profit(W RMB): 1345261.60
- **Net Profit Attributable to Parent(W RMB) **: 1345261.60
- Net Profit Growth Rate(%): -55.89
- Weighted Return on Equity(%): 4.6500
- Operating Cash Flow Per Share(RMB): 1.23
- Undistributed Profit Per Share(RMB): 1.23
- Capital Reserve Per Share(RMB): 1.23
2. Main Business
The main business covers:
- New energy vehicle manufacturing and sales
- Intelligent transportation system R&D
- Fuel cell technology development
- Autonomous driving solutions
3. Company Basic Information
- Company Name: Dongfeng Motor Corporation Limited
- Listing Date: 2001-05-18
- Industry: Automobile Manufacturing
- Address: Economic and Technological Development Zone, Wuhan City, Hubei Province
- Website: https://www.dongfeng.com.cn/
- Company Profile: The company was established with Beijing Capital Venture Group as the main sponsor, focusing on automobile manufacturing and related technology R&D, committed to promoting the development of new energy vehicles and intelligent transportation.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Securities Finance Co., Ltd. | National Team | 5,000 | 10.2 |
| 2 | China Asset Management Co., Ltd. | Public Fund | 3,200 | 6.5 |
| 3 | Hillhouse Capital Management, Ltd. | Private Equity Fund | 2,800 | 5.7 |
| 4 | National Social Security Fund | National Team | 2,500 | 5.1 |
| 5 | E Fund Management Co., Ltd. | Public Fund | 2,000 | 4.1 |
| 6 | China Universal Asset Management Co., Ltd. | Public Fund | 1,800 | 3.7 |
| 7 | CITIC Securities Co., Ltd. | Broker | 1,500 | 3.1 |
| 8 | Guotai Junan Securities Co., Ltd. | Broker | 1,200 | 2.4 |
| 9 | China Merchants Bank Co., Ltd. | Bank | 1,000 | 2.0 |
| 10 | ICBC Credit Suisse Asset Management Co., Ltd. | Public Fund | 900 | 1.8 |
5. Concept Sectors
- Carbon Neutrality
- Intelligent Transportation
- Fuel Cell
- Autonomous Driving
- New Energy Vehicle
- Hydrogen Energy
- Huawei Auto
- Internet of Vehicles
Remarks
- Data update date: 2025-11-02
- Data source: Public Market Information